172 related articles for article (PubMed ID: 22217630)
21. Derivation and validation of QRISK, a new cardiovascular disease risk score for the United Kingdom: prospective open cohort study.
Hippisley-Cox J; Coupland C; Vinogradova Y; Robson J; May M; Brindle P
BMJ; 2007 Jul; 335(7611):136. PubMed ID: 17615182
[TBL] [Abstract][Full Text] [Related]
22. Development and validation of risk prediction equations to estimate future risk of heart failure in patients with diabetes: a prospective cohort study.
Hippisley-Cox J; Coupland C
BMJ Open; 2015 Sep; 5(9):e008503. PubMed ID: 26353872
[TBL] [Abstract][Full Text] [Related]
23. Living risk prediction algorithm (QCOVID) for risk of hospital admission and mortality from coronavirus 19 in adults: national derivation and validation cohort study.
Clift AK; Coupland CAC; Keogh RH; Diaz-Ordaz K; Williamson E; Harrison EM; Hayward A; Hemingway H; Horby P; Mehta N; Benger J; Khunti K; Spiegelhalter D; Sheikh A; Valabhji J; Lyons RA; Robson J; Semple MG; Kee F; Johnson P; Jebb S; Williams T; Hippisley-Cox J
BMJ; 2020 Oct; 371():m3731. PubMed ID: 33082154
[TBL] [Abstract][Full Text] [Related]
24. Identifying women with undetected ovarian cancer: independent and external validation of QCancer(®) (Ovarian) prediction model.
Collins GS; Altman DG
Eur J Cancer Care (Engl); 2013 Jul; 22(4):423-9. PubMed ID: 23121234
[TBL] [Abstract][Full Text] [Related]
25. Predicting risk of osteoporotic fracture in men and women in England and Wales: prospective derivation and validation of QFractureScores.
Hippisley-Cox J; Coupland C
BMJ; 2009 Nov; 339():b4229. PubMed ID: 19926696
[TBL] [Abstract][Full Text] [Related]
26. Predicting the risk of prostate cancer in asymptomatic men: a cohort study to develop and validate a novel algorithm.
Hippisley-Cox J; Coupland C
Br J Gen Pract; 2021 May; 71(706):e364-e371. PubMed ID: 33875417
[TBL] [Abstract][Full Text] [Related]
27. Predicting risk of upper gastrointestinal bleed and intracranial bleed with anticoagulants: cohort study to derive and validate the QBleed scores.
Hippisley-Cox J; Coupland C
BMJ; 2014 Jul; 349():g4606. PubMed ID: 25069704
[TBL] [Abstract][Full Text] [Related]
28. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
29. Development and validation of risk prediction equations to estimate survival in patients with colorectal cancer: cohort study.
Hippisley-Cox J; Coupland C
BMJ; 2017 Jun; 357():j2497. PubMed ID: 28620089
[No Abstract] [Full Text] [Related]
30. Predicting risk of type 2 diabetes in England and Wales: prospective derivation and validation of QDScore.
Hippisley-Cox J; Coupland C; Robson J; Sheikh A; Brindle P
BMJ; 2009 Mar; 338():b880. PubMed ID: 19297312
[TBL] [Abstract][Full Text] [Related]
31. Predictive values for different cancers and inflammatory bowel disease of 6 common abdominal symptoms among more than 1.9 million primary care patients in the UK: A cohort study.
Herbert A; Rafiq M; Pham TM; Renzi C; Abel GA; Price S; Hamilton W; Petersen I; Lyratzopoulos G
PLoS Med; 2021 Aug; 18(8):e1003708. PubMed ID: 34339405
[TBL] [Abstract][Full Text] [Related]
32. Risk prediction of covid-19 related death and hospital admission in adults after covid-19 vaccination: national prospective cohort study.
Hippisley-Cox J; Coupland CA; Mehta N; Keogh RH; Diaz-Ordaz K; Khunti K; Lyons RA; Kee F; Sheikh A; Rahman S; Valabhji J; Harrison EM; Sellen P; Haq N; Semple MG; Johnson PWM; Hayward A; Nguyen-Van-Tam JS
BMJ; 2021 Sep; 374():n2244. PubMed ID: 34535466
[TBL] [Abstract][Full Text] [Related]
33. Clinical assessment to determine the risk of bowel cancer using Symptoms, Age, Mass and Iron deficiency anaemia (SAMI).
Thompson MR; O'Leary DP; Flashman K; Asiimwe A; Ellis BG; Senapati A
Br J Surg; 2017 Sep; 104(10):1393-1404. PubMed ID: 28634990
[TBL] [Abstract][Full Text] [Related]
34. Individualising the risks of statins in men and women in England and Wales: population-based cohort study.
Hippisley-Cox J; Coupland C
Heart; 2010 Jun; 96(12):939-47. PubMed ID: 20489220
[TBL] [Abstract][Full Text] [Related]
35. Identification of ovarian cancer symptoms in health insurance claims data.
Devlin SM; Diehr PH; Andersen MR; Goff BA; Tyree PT; Lafferty WE
J Womens Health (Larchmt); 2010 Mar; 19(3):381-9. PubMed ID: 20156131
[TBL] [Abstract][Full Text] [Related]
36. Does the SORG Algorithm Predict 5-year Survival in Patients with Chondrosarcoma? An External Validation.
Bongers MER; Thio QCBS; Karhade AV; Stor ML; Raskin KA; Lozano Calderon SA; DeLaney TF; Ferrone ML; Schwab JH
Clin Orthop Relat Res; 2019 Oct; 477(10):2296-2303. PubMed ID: 31107338
[TBL] [Abstract][Full Text] [Related]
37. Predicting cardiovascular risk in England and Wales: prospective derivation and validation of QRISK2.
Hippisley-Cox J; Coupland C; Vinogradova Y; Robson J; Minhas R; Sheikh A; Brindle P
BMJ; 2008 Jun; 336(7659):1475-82. PubMed ID: 18573856
[TBL] [Abstract][Full Text] [Related]
38. Temporal patterns of conditions and symptoms potentially associated with ovarian cancer.
Wynn ML; Chang S; Peipins LA
J Womens Health (Larchmt); 2007 Sep; 16(7):971-86. PubMed ID: 17903074
[TBL] [Abstract][Full Text] [Related]
39. The performance of seven QPrediction risk scores in an independent external sample of patients from general practice: a validation study.
Hippisley-Cox J; Coupland C; Brindle P
BMJ Open; 2014 Aug; 4(8):e005809. PubMed ID: 25168040
[TBL] [Abstract][Full Text] [Related]
40. Identifying patients with undetected renal tract cancer in primary care: an independent and external validation of QCancer® (Renal) prediction model.
Collins GS; Altman DG
Cancer Epidemiol; 2013 Apr; 37(2):115-20. PubMed ID: 23280341
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
